knowledge -WSS

knowledge

author：hotspot 2025-09-29 21:28:14 - browse：8

Adam's take main illustration — Molly Ferguson/STAT

Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics:

A take-under deal feels meh for biotech sector sentiment.Bristol is paying $58 per share in cash for Mirati, which closed Friday at $60. Granted, Mirati was trading in the $30 range in September, so from there, the roughly 50% premium isn’t terrible. But as Mizuho strategist Jared Holz pointed out, investors would liked to have seen Mirati go for $75-$100 per share.

With the closely watched XBI biotech index down 13% for the year, every M&A deal helps improve sentiment, but this one — maybe just a little. Bristol is paying $4.8 billion in cash to acquire Mirati, or $3.7 billion after accounting for Mirati’s cash. It’s a small bolt-on acquisition for Bristol, which isn’t overpaying.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Driven by the pandemic, applicants flood public health schools

WSS

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Focused ultrasound for uterine fibroids: an uphill battle

Study identifies new proteins linked to dementia risk 25 years later

Hospitals struggle to profit from CAR

Stanford president's case begs question: Who takes blame?

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

knowledge

knowledge

entertainment

In Memoriam: Notable people who died in 2023

David Sabatini, ex

Alkermes shareholders re

Affordable Connectivity Program vital to health care, experts say

What does generative AI mean for health care? We asked experts

Lab trade group sues FDA to halt regulation of lab

Guidelines to prevent youth baseball injuries need more muscle

Study identifies new proteins linked to dementia risk 25 years later

Hepatitis C has a cure — but many Americans still lack access to it

Tocagen's brain cancer gene therapy trial continues. Investors worry

entertainment

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Divers poised to search for children washed away in Pennsylvania flash flood

Report: NIH

7 more heat

Judge rejects Trump's request to move Stormy Daniels hush

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Wikipedia

entertainment

explore

focus